Oxygenta Pharmaceutical Ltd Postpones Board Meeting, Reschedules to July 27
Oxygenta Pharmaceutical Ltd has announced a postponement of its scheduled Board Meeting, rescheduling the event to Monday, July 27, 2026. The meeting concerns the review and approval of key financial results for the quarter ending June 30, 2026.The Board Meeting, which was originally set for Saturday, July 25, 2026, will now be held at the company's corporate office on the revised date.
The meeting is scheduled to review and approve several critical items related to the company's performance in the recent quarter. These items include:
- Unaudited financial results for the quarter ended June 30, 2026.
- Limited Review Report for the quarter ended June 30, 2026.
- Any other business with the permission of the Chair.
Stock Price Movement
Oxygenta Pharmaceutical Ltd shares settled at ₹51.35 on Friday, surging 6.42% after the close of trade. The stock traded within its session range, dipping to a low of ₹48.50 before climbing to hit an intraday high of ₹51.35.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.